Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study
van Kesteren, Charlotte, Twelves, Chris, Bowman, Angela, Hoekman, Klaas, López-Lázaro, Luis, Jimeno, José, Guzman, Cecilia, Mathôt, Ron AA, Simpson, Andrew, Vermorken, Jan B, Smyth, John, Schellens, JТом:
13
Мова:
english
Журнал:
Anti-Cancer Drugs
DOI:
10.1097/00001813-200204000-00007
Date:
April, 2002
Файл:
PDF, 184 KB
english, 2002
File converter
Більше результатів пошуку
More benefits 
